Racial and ethnic disparities in nasopharyngeal cancer with an emphasis among Asian Americans.

Authors

null

Qian Wang

Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

Qian Wang, Hui Xie, Changchuan Jiang, Yaning Zhang, Yannan Li, Nicholas Theodoropoulos, Paolo Boffetta

Organizations

Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, Roswell Park Cancer Center, Buffalo, NY, Department of Surgery Cleveland Clinic, Cleveland, OH, Center of Thoracic Oncology, Tisch Cancer Institue, Icahn School of Medicine at Mount Sinai, New York, NY, Icahn School of Medicine at Mount Sinai Morningside and West, New York, NY, Stony Brook University, New York, NY

Research Funding

No funding received
None

Background: Nasopharyngeal cancer (NPC) is characterized by a distinct geographic distribution which reflects genetic predispositions, with highest incidence in Southeastern Asia and Southern China. It continues to cause a significant health burden among Asian Americans (AAs), which is a fast growing but understudied racial group. Prior studies investigating NPC combined all AA groups which may mask heterogeneities among AA subgroups. We aimed to examine the disparities in NPC by dividing AAs into four major ethnic groups - Chinese, Filipinos, Vietnamese, and Japanese Americans. Methods: NPC cases were identified from the Surveillance, Epidemiology, and End Result (SEER) 18 database from 1975-2016. Information regarding age, sex, race/ethnicity, education, income, % of foreign born, marital status, region of SEER registry, stage, histology, grade, surgery, chemotherapy, and radiation therapy were extracted. Multivariate-adjusted Cox proportional hazard regression and Fine-Gray sub-distribution hazard models were used to calculate overall and cause-specific mortality. SEER*Stat was used to calculated age-adjusted incidence. Results: Among a total of 11,737 NPC patients, 42.2% were non-Hispanic White (NHW), 10.7% non-Hispanic Black (NHB), 7.1% Hispanics, 18.9% Chinese, 7.6% Filipinos, 4.8% Vietnamese, 1.0% Japanese and 7.7% other Asians. AAs continue to have the highest NPC incidence among all racial groups despite of an overall decreasing trend. Japanese were significantly more likely to be diagnosed at localized stage, having low grade tumor and having keratinizing squamous cell carcinoma histology compared to other AAs. Compared to NHW, Filipino Americans had decreased mortality (HR = 0.90; 95%CI:0.84-0.98). Chinese (HR = 0.95; 95%CI: 0.90-1.01), and Vietnamese (HR = 0.94; 95%CI: 0.86-1.03) also observed marginally reduced mortality but not Japanese Americans (HR = 1.09; 95%CI: 0.90-1.32). No differences in NPC-specific mortality by race/ethnicity groups were found. In addition, Chinese, Filipino and Vietnamese Americans with NPC were less likely to die of other cancer and cardiovascular disease than NHW, but no such differences were observed among NHB, Hispanics or Japanese Americans. Conclusions: Asian Americans have been historically studied as one single racial group mostly due to limited sample size, despite that it is consistent of a diverse population with different genetic makeup, socioeconomic status, cultural background, health behaviors, and health care access. Our novel finding that significant disparities exist within AA NPC patients in regard to demographic and clinical features, overall and cause-specific mortality underlines the importance of adequate AA-subgroup specific sample size in future studies in order to understand the prognostic role of ethnicity in NPC, and advocates more ethnically and culturally tailored cancer care delivery.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2021 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cost, Value, and Policy; Health Equity and Disparities; Patient Experience

Track

Cost, Value, and Policy,Technology and Innovation in Quality of Care,Health Care Access, Equity, and Disparities,Patient Experience,Quality, Safety, and Implementation Science

Sub Track

Health Disparities

Citation

J Clin Oncol 39, 2021 (suppl 28; abstr 118)

DOI

10.1200/JCO.2020.39.28_suppl.118

Abstract #

118

Poster Bd #

Online Only

Abstract Disclosures

Similar Abstracts

First Author: Qian Wang

Abstract

2023 ASCO Quality Care Symposium

Association of area-level structural racism with racial disparities in cancer mortality.

First Author: Katherine Elizabeth Reeder-Hayes

First Author: Stephanie Navarro

Abstract

2022 ASCO Genitourinary Cancers Symposium

Disparities in prostate cancer: An ethnicity comparative focus among Hispanic Americans versus non-Hispanic whites.

First Author: Alejandro Recio-Boiles